Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).

Rinnerthaler, G, Gampenrieder, SP, Petzer, A, Burgstaller, S, Fuchs, D, Rossmann, D, Balic, M, Egle, D, Rumpold, H, Singer, CF, Bartsch, R, Petru, E, Melchardt, T, Ulmer, H, Mlineritsch, B, Greil, R.

https://www.ncbi.nlm.nih.gov/pubmed/30400780